News
AbbVie licensed IGI's trispecific myeloma drug ISB 2001 in a deal worth up to $1.925 billion following strong early-phase ...
Core Scientific's HPC and AI progress is overshadowed by investor concerns over its all-stock merger with CoreWeave.
Bank of America says SoFi may benefit from student loan reforms, with potential gains in loan volume, fee revenue, and ...
Amazon's Project Kuiper satellite launches have begun, with a target of offering consumer service in late 2025. Analyst ...
Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...
Costco posted $26.44 billion in June sales, rising 8% YoY. BofA keeps Overweight rating, citing strong global growth and ...
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $19.0, along with a high estimate of $20.00 and a low estimate of $18.00. This current ...
Following our analysis of the options activities associated with Ultragenyx Pharmaceutical, we pivot to a closer look at the company's own performance. With a volume of 9,702,498, the price of RARE is ...
The general mood among these heavyweight investors is divided, with 46% leaning bullish and 46% bearish. Among these notable options, 8 are puts, totaling $248,926, and 18 are calls, amounting to ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $65.0 to $150.0 for Estee Lauder Cos over the last 3 months.
For Ethereum staking, returns may range from 50% to 100% of the official protocol rate, due to the platform's method of ...
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $140.33, along ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results